Infection complicating bone marrow transplantation: what are the risks and can they be reduced?
D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D017053:Infection Control; D017708:Leukocyte Transfusion; D009181:Mycoses / Q000517:prevention & control; D010356:Patient Isolation; D012306:Risk; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014777:Virus Diseases / Q000517:prevention & control
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole